Highlights of House user fee reauthorization legislation

The House Energy and Commerce Committee has reached bipartisan agreement on a set of provisions to include in the FDA Amendments of 2022 legislation reauthorizing user fees and modifying and extending FDA’s missions.

The committee is continuing to seek bipartisan agreement on additional provisions that could be added to the bill. Separately, the Senate Health, Education, Labor and Pensions Committee is developing legislation to accompany user fee reauthorization and that it is expected to release after the Memorial Day recess...